Predictive value of aspartate aminotransferase-to-alanine aminotransferase ratio for contrast-associated acute kidney injury in patients undergoing elective percutaneous coronary intervention. Issue 5 (May 2022)

• Record Type: Journal Article
• Authors: He, Hao-ming; He, Chen; Zhang, Si-cheng; You, Zhe-bin; Lin, Xue-qin; Luo, Man-qing; Lin, Mao-qing; Guo, Yan-song; Zheng, Wei-ping; Lin, Kai-yang
• Is Part Of: Journal of cardiology. Volume 79:Issue 5(2022)
• Page Start: 618
• Page End: 625
• Publication Date: 2022-05
• Subjects: De-Ritis ratio -- Contrast-associated acute kidney injury -- Percutaneous coronary intervention -- Mortality; Cardiology -- Periodicals; 616.12
• DOI: 10.1016/j.jjcc.2021.11.009
• Languages: English
• ISSNs: 0914-5087

Abstract

Highlights: Pre-procedure liver insufficiency was correlated with poor prognosis after percutaneous coronary intervention (PCI). The De-Ritis ratio reflects the severity of liver insufficiency. High De-Ritis ratio was associated with contrast-associated acute kidney injury. High De-Ritis ratio was an independent risk factor for long-term mortality. De-Ritis ratio may contribute to the risk stratification in patients undergoing PCI. Abstract: Background: Pre-procedure liver insufficiency has been demonstrated as a poor prognostic factor after percutaneous coronary intervention (PCI). Recent research discovered that the aspartate aminotransferase-to-alanine aminotransferase ratio (De-Ritis ratio) reflects the severity of liver insufficiency and was associated with adverse outcomes. We aim to evaluate the predictive value of the De-Ritis ratio for contrast-associated acute kidney injury (CA-AKI) and long-term mortality in patients undergoing elective PCI. Methods: We retrospectively enrolled 5780 consenting patients undergoing elective PCI between January 2012 and December 2018. CA-AKI was defined as an increase in serum creatinine ≥0.3 mg/dl or ≥50% within 48 h after the administration of contrast media. Results: The incidence of CA-AKI was 6.3% ( n = 363). The De-Ritis ratio >1.30 was identified as the best cut-off value for CA-AKI prediction. The De-Ritis ratio showed an area under the curve (AUC) of 0.636 [95% confidence interval (CI): 0.605–0.667] in predicting CA-AKI, which was significantly greater than alanine aminotransferase ( p <0.001) and aspartate aminotransferase ( p = 0.012) alone. Furthermore, compared to currently recognized liver function assessment tools, the predictive value of the De-Ritis ratio on CA-AKI was similar to the MELD score (AUC: 0.636 vs 0.626, p = 0.631) and higher than the MELD-XI score (AUC: 0.636 vs 0.561, p <0.001). Multivariate logistic analysis showed that the De-Ritis ratio >1.30 was independently associated with CA-AKI (odds ratio=1.551, 95% CI: 1.185–2.030, p = 0.001). The addition of the De-Ritis ratio to the fully adjusted logistic regression model has significant incremental effects on the risk prediction for CA-AKI with a continuous net reclassification improvement of 0.395 ( p <0.001) and an integrated discrimination improvement of 0.005 ( p = 0.018). Additionally, the De-Ritis ratio >1.30 was significantly associated with long-term mortality (hazard ratio=1.285, 95% CI: 1.007–1.641, p = 0.044). Conclusions: The De-Ritis ratio was an independent risk factor for CA-AKI and long-term mortality in patients undergoing elective PCI. Graphical abstract: Image, graphical abstract